1. Home
  2. MUSA vs LEGN Comparison

MUSA vs LEGN Comparison

Compare MUSA & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Murphy USA Inc.

MUSA

Murphy USA Inc.

HOLD

Current Price

$409.28

Market Cap

7.6B

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$17.79

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MUSA
LEGN
Founded
1996
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
5.9B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
MUSA
LEGN
Price
$409.28
$17.79
Analyst Decision
Buy
Buy
Analyst Count
7
14
Target Price
$445.00
$63.46
AVG Volume (30 Days)
378.8K
2.1M
Earning Date
05-06-2026
01-01-0001
Dividend Yield
0.61%
N/A
EPS Growth
N/A
N/A
EPS
24.10
N/A
Revenue
$21,529,400,000.00
N/A
Revenue This Year
$17.24
$67.56
Revenue Next Year
$3.49
$43.20
P/E Ratio
$17.12
N/A
Revenue Growth
N/A
N/A
52 Week Low
$345.23
$16.24
52 Week High
$523.09
$45.30

Technical Indicators

Market Signals
Indicator
MUSA
LEGN
Relative Strength Index (RSI) 53.90 40.66
Support Level $388.47 $16.24
Resistance Level $433.18 $23.68
Average True Range (ATR) 16.18 0.84
MACD 3.04 0.11
Stochastic Oscillator 81.32 5.47

Price Performance

Historical Comparison
MUSA
LEGN

About MUSA Murphy USA Inc.

Murphy USA operates more than 1,700 fueling stations and convenience stores primarily across the Midwest and Southeastern United States. The firm owns about 75% of its locations, with most stores situated in high-traffic areas near Walmart supercenters. Murphy's stores typically range from 1,400-2,800 square feet, with most of its in-store sales derived from tobacco and nicotine products. The company acquired about 150 QuickChek stores in 2021, boosting its presence in grocery and foodservice. Murphy generates about two thirds of its profit from fuel retailing, with the remaining third coming from in-store sales.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: